Acute hypertriglyceridemia and hyperglycemia related to mirtazapine: A case report

被引:0
|
作者
Sahan, Ebru [1 ]
Tangilntiz, Aise [2 ]
机构
[1] Marmara Univ, Pendik Training & Res Hosp, Dept Psychiat, Fevzi Cakmak Mah Muhsin Yazicioglu Cad 10, TR-34899 Istanbul, Turkey
[2] Bezmialem Fdn Univ, Fac Med, Dept Psychiat, Adnan Menderes Blvd Vatan Rd, Istanbul, Turkey
来源
KUWAIT MEDICAL JOURNAL | 2021年 / 53卷 / 02期
关键词
adverse effects; depression; hyperglycemia; hypertriglyceridemia; mirtazapine; INDUCED PANCREATITIS; SECONDARY; INPATIENTS; THERAPY; SAFETY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 42-year-old woman was hospitalized with depression and was started on mirtazapine 15 mg/day. Just one week after starting mirtazapine, severe hypertriglyceridemia and hyperglycemia were detected. Although these metabolic adverse effects have been reported before, to our knowledge this is the first case of hypertriglyceridemia and hyperglycemia occurring so early (just one week) after initiation of mirtazapine. The patient's glucose and triglyceride normalized nine days after discontinuation of mirtazapine. This case emphasizes the importance of regular glucose and triglyceride measurements at baseline and then regular monitoring in patients receiving mirtazapine treatment.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 50 条